| |
| |
|
| Insider
Information: |
Papa Joseph C |
| Relationship: |
Director |
| City: |
Corona |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,952,222 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,736,946 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,952,222 |
|
|
| Total
Value |
$17,736,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 26.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
Chmn & CEO, Pharm Tech... |
2004-12-13 |
14,400 |
|
0 |
Premium* |
|
|
Perrigo Co |
PRGO |
President and CEO, Cha... |
2013-12-18 |
0 |
2006-10-09 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2022-05-10 |
1,427,568 |
2016-05-02 |
0 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Director |
2023-06-16 |
0 |
2023-06-16 |
0 |
Premium* |
|
|
Bausch & Lomb Corp |
BLCO |
CEO & Chairman, Director |
2022-05-05 |
472,222 |
2022-05-05 |
0 |
Premium* |
|
|
Candel Therapeutics, Inc. |
CADL |
Director |
2022-12-09 |
38,032 |
2022-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
317,089 |
1,162,912 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Chairman & CEO |
• • – |
2022-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
208,231 |
1,239,650 |
0 |
- |
|
| BLCO |
Bausch & Lomb Corp |
CEO & Chairman |
• • – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
472,222 |
472,222 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2022-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
366,130 |
1,461,282 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,278 |
17,278 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
7,278 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,278) |
0 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Director |
– • – |
2022-12-08 |
4 |
B |
$1.70 |
$5,124 |
D/D |
3,014 |
3,014 |
2.39 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Director |
– • – |
2022-12-09 |
4 |
B |
$1.94 |
$67,935 |
D/D |
35,018 |
38,032 |
2.39 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2022-05-10 |
4 |
D |
$9.40 |
$316,912 |
D/D |
(33,714) |
1,427,568 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2020-09-14 |
4 |
D |
$15.40 |
$55,794 |
D/D |
(3,623) |
804,980 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2020-09-15 |
4 |
D |
$15.91 |
$81,380 |
D/D |
(5,115) |
799,865 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2018-03-13 |
4 |
B |
$16.05 |
$481,500 |
D/D |
30,000 |
719,019 |
2.81 |
- |
|
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2020-05-04 |
4 |
D |
$17.16 |
$1,638,591 |
D/D |
(95,489) |
808,603 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2008-12-01 |
4 |
OE |
$17.29 |
$38,003 |
D/D |
2,198 |
72,595 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2008-12-02 |
4 |
OE |
$17.29 |
$480,697 |
D/D |
27,802 |
98,199 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2009-11-25 |
4 |
OE |
$17.29 |
$345,800 |
D/D |
20,000 |
102,131 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-02-22 |
4 |
OE |
$17.29 |
$259,350 |
D/D |
15,000 |
130,337 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-03-22 |
4 |
OE |
$17.29 |
$297,324 |
D/D |
15,000 |
130,337 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-12-29 |
4 |
OE |
$17.29 |
$172,900 |
D/D |
10,000 |
120,912 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-01-19 |
4 |
OE |
$17.29 |
$86,450 |
D/D |
5,000 |
115,912 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-02-22 |
4 |
OE |
$17.29 |
$96,182 |
D/D |
5,000 |
113,870 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2018-05-03 |
4 |
D |
$18.31 |
$1,683,458 |
D/D |
(91,942) |
627,077 |
0 |
- |
|
137 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
